Europe
Under terms of the deal, Boehringer has the option to acquire Autifony’s Kv3.1/3.2 positive modulator platform, which includes the company’s lead compound AUT00206.
A look at three of the best performing medtech stocks out there right now.
Perrigo is expected to face competition from Swiss food giant Nestle and the private equity owners of German drug firm Stada.
Boehringer’s global head of information technology, Michael Schmelmer, will replace Menne on Jan. 1, 2018.
Bruno Strigini, the CEO of Novartis Oncology, plans to exit the company’s Executive Committee by Dec. 31, 2017, and leave entirely in early 2018.
The approval of HAnano Surface in the United States has been executed in accordance with the new 510(k) legislation for medical devices.
The Mass. Attorney General said the deal will resolve an investigation by her office and those in four other states related to Medtronic’s promotion of Infuse.
A lot containing 18,000 gel-filled syringes of Sinvisc-One tested positive for microbial contamination.
reMYND’s pre-clinical diabetes therapy ReS39 will get a significant boost after the company entered a licensing agreement with noted European diabetes company Novo Nordisk.
The French executive made the public apology after he was castigated by SAGIP Rep. Rodante Marcoleta for his company’s “insensitivity” to the concerns of the Filipino public.
PRESS RELEASES